Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023
- ALL1269549
- 63 Pages
- July 2017
- Diagnostic and Biotech
Blood is a major necessity for patients suffering from injuries and viral infections, which require blood transfusion. The patients are either given whole blood or blood components for quick recovery and healing, resulting into increased demand for blood banks.
The global blood market was valued at $33,500 million in 2016, and is estimated to reach $45,982 million by 2023, registering a CAGR of 4.6% from 2017 to 2023. The major factors that enhance the market growth are increase in geriatric population, rise in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments. However, rise in minimal invasive technology, which no longer requires blood transfusion restrains the market growth.
The global blood market is segmented by product, end user, and geography. Based on product, it is divided into whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients. Based on whole blood collection, the market is bifurcated into system and reagents. On the basis of source plasma collection, it is divided into system and reagents. Blood therapeutics are categorized into intravenous immunoglobulin (IVIG), factor IX, factor VIII, hyperimmune, and albumins. Blood typing products are classified into system and reagents. Blood screening is further divided into systems and reagents. Blood processing equipment & associated products are categorized into systems and reagents.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America market accounted for significant share in the global market in 2016, owing to a well-developed healthcare industry and rise in number of patient population requiring blood & blood components.
KEY BENEFITS
- The study provides an in-depth analysis of the global blood market, with the current trends and future estimations to elucidate the imminent investment pockets.
- The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
- Extensive analysis of the market based on the product and end user elucidates the prevailing opportunities in these segments.
- Comprehensive analysis of geographical regions is provided to determine the latent regional opportunities.
- Key players operating in the market and their strategies are profiled to determine the competitive outlook of the market.
KEY MARKET SEGMENTS
BY PRODUCT
- Whole Blood Collection
- Whole Blood Collection Systems
- Whole Blood Collection Reagents
- Source Plasma Collections
- Source Plasma Collection Systems
- Source Plasma Collection Reagents
- Blood Therapeutics
- IVIG (Intravenous Immunoglobulin)
- Factor IX
- Factor VIII
- Hyperimmune
- Albumins
- Blood Typing Products
- Blood Typing Systems
- Blood Typing Reagents
- Blood Screening
- Blood Screening Systems
- Blood Screening Reagents
- Blood Processing Equipment & Associated Products
- Blood Processing Equipment Systems
- Blood Processing Equipment Reagents
BY END USER
- Blood & Blood Component Bank
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Hospitals
- Others (Academic Institutes & Research Laboratories)
BY GEOGRAPHY
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Abbott Laboratories
- Becton, Dickinson & Co.
- Baxter International Inc.
- CSL Behring
- Grifols International SA
- Immucor
- Novartis
- Novo Nordisk
- Ortho Clinical Diagnostics
- Roche Diagnostics
LIST OF OTHER PLAYERS IN THE VALUE CHAIN
(These players are not profiled in the report, but can be included on request)
- Medimmune (AstraZeneca)
- Fresenius Kabi
- Macopharma
- Nipro Medical Corporation
- Sarstedt AG & Co.
- Thermo Fisher Scientific, Inc.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS,2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Increase in geriatric population
3.5.1.2. Technological advancement in medical technology for donor screening
3.5.1.3. Advancement in blood transfusion instruments
3.5.2. Restraints
3.5.2.1. Advancement in minimal invasive technology
3.5.3. Opportunities
3.5.3.1. Improvement in the healthcare facilities in Asia-Pacific
CHAPTER 4 BLOOD MARKET, BY PRODUCT
4.1. OVERVIEW
4.2. WHOLE BLOOD COLLECTION
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Market by whole blood collection type
4.2.4.1. Whole Blood Collection Systems
4.2.4.1.1. Market size and forecast
4.2.4.2. Whole Blood Collection Reagents
4.2.4.2.1. Market size and forecast
4.3. SOURCE PLASMA COLLECTION
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Source Plasma Collection Systems
4.3.4.1. Market size and forecast
4.3.5. Source Plasma Collection Reagents
4.3.5.1. Market size and forecast
4.4. BLOOD THERAPEUTICS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. IVIG (Intravenous Immunoglobulin)
4.4.4.1. Market size and forecast
4.4.5. Factor IX
4.4.5.1. Market size and forecast
4.4.6. Factor VIII
4.4.6.1. Market size and forecast
4.4.7. Factor IX
4.4.7.1. Market size and forecast
4.4.8. Hyperimmune
4.4.8.1. Market size and forecast
4.4.9. Albumins
4.4.9.1. Market size and forecast
4.4.10. Others
4.4.10.1. Market size and forecast
4.5. BLOOD TYPING PRODUCTS
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Blood Typing Systems
4.5.4.1. Market size and forecast
4.5.5. Blood Typing Reagents
4.5.5.1. Market size and forecast
4.6. BLOOD SCREENING
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Blood Screening Systems
4.6.4.1. Market size and forecast
4.6.5. Blood Screening Reagents
4.6.5.1. Market size and forecast
4.7. BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Blood Processing Equipment Systems
4.7.4.1. Market size and forecast
4.7.5. Blood Processing Equipment Reagents
4.7.5.1. Market size and forecast
CHAPTER 5 BLOOD MARKET, BY END USER
5.1. OVERVIEW
5.2. BLOOD & BLOOD COMPONENT BANK
5.2.1. Market size and forecast
5.3. DIAGNOSTIC LABORATORIES
5.3.1. Market size and forecast
5.4. AMBULATORY SURGICAL CENTERS
5.4.1. Market size and forecast
5.5. HOSPITALS
5.5.1. Market size and forecast
CHAPTER 6 BLOOD MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.: market size and forecast
6.2.5. Canada: market size and forecast
6.2.6. Mexico: market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany: market size and forecast
6.3.5. France market size and forecast
6.3.6. UK: market size and forecast
6.3.7. Italy: market size and forecast
6.3.8. Spain: market size and forecast
6.3.9. Rest of Europe: market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan: market size and forecast
6.4.5. China market size and forecast
6.4.6. India: market size and forecast
6.4.7. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Latin America: market size and forecast
6.5.5. Middle East market size and forecast
6.5.6. Africa: market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Overview
7.1.1. Operating business segments
7.1.1. Business performance
7.1.2. Key strategic moves & developments
7.2. BAXTER INTERNATIONAL INC.
7.2.1. Overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments
7.3. BECTON, DICKINSON & CO.
7.3.1. Overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves & developments
7.4. CSL BEHRING
7.4.1. Overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves & developments
7.5. IMMUCOR
7.5.1. Overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves & developments
7.6. NOVARTIS
7.6.1. Overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves & developments
7.7. NOVO NORDISK
7.7.1. Overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments
7.8. ORTHO CLINICAL DIAGNOSTICS
7.8.1. Overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves & developments
7.9. ROCHE DIAGNOSTICS
7.9.1. Overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves & developments
7.10. GRIFOLS INTERNATIONAL SA
7.10.1. Overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves & developments
LIST OF TABLES
TABLE 1. GLOBAL BLOOD MARKET, BY PRODUCT, 2016-2023, ($ MILLION)
TABLE 2. GLOBAL BLOOD MARKET FOR WHOLE BLOOD COLLECTION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. GLOBAL WHOLE BLOOD COLLECTION MARKET, BY TYPE, 2016-2023, ($ MILLION)
TABLE 4. GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL BLOOD INDUSTRY MARKET FOR SOURCE PLASMA COLLECTION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. GLOBAL SOURCE PLASMA COLLECTION SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL SOURCE PLASMA COLLECTION REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. GLOBAL BLOOD INDUSTRY MARKET FOR BLOOD THERAPEUTICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL IVIG (INTRAVENOUS IMMUNOGLOBULIN), BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL FACTOR IX, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL FACTOR VIII, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. GLOBAL FACTOR IX, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. GLOBAL HYPERIMMUNE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL ALBUMINS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OTHERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. GLOBAL BLOOD MARKET FOR BLOOD TYPING PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. GLOBAL BLOOD TYPING SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL BLOOD TYPING REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. GLOBAL BLOOD MARKET FOR BLOOD SCREENING, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. GLOBAL BLOOD SCREENING SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. GLOBAL BLOOD SCREENING REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. GLOBAL BLOOD MARKET FOR BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. GLOBAL BLOOD MARKET, BY END USER, 2016-2023 ($ MILLION)
TABLE 27. GLOBAL BLOOD MARKET FOR BLOOD & BLOOD COMPONENT BANK, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. GLOBAL BLOOD MARKET FOR DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29. GLOBAL BLOOD FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. GLOBAL BLOOD MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. GLOBAL BLOOD MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA: BLOOD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. EUROPE: BLOOD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. EUROPE: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 37. EUROPE: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC: BLOOD MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 39. ASIA-PACIFIC: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 40. ASIA-PACIFIC: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. LAMEA: BLOOD MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 42. LAMEA: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. LAMEA: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 44. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 45. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 46. BECTON, DICKINSON & CO.: COMPANY SNAPSHOT
TABLE 47. CSL BEHRING.: COMPANY SNAPSHOT
TABLE 48. IMMUCOR: COMPANY SNAPSHOT
TABLE 49. NOVARTIS: COMPANY SNAPSHOT
TABLE 50. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 51. ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 52. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 53. GRIFOLS INTERNATIONAL SA: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. BLOOD MARKET: MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 5. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 6. TOP INVESTMENT POCKETS IN BLOOD MARKET
FIGURE 7. MARKET SHARE ANALYSIS: BLOOD MARKET, 2016
FIGURE 13. U.S.: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 14. CANADA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 15. MEXICO: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 16. GERMANY: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 17. FRANCE: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 18. UK: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 19. ITALY: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 20. SPAIN: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 21. REST OF EUROPE: BLOOD INDUSTRY MARKET, 2016-2023($MILLION)
FIGURE 22. JAPAN: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 23. CHINA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 24. INDIA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 25. REST OF ASIA-PACIFIC: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 26. LATIN AMERICA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 27. MIDDLE EAST: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 28. AFRICA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 29. ABBOTT LABORATORIES: REVENUE, 2013-2015 ($MILLION)
FIGURE 30. BAXTER INTERNATIONAL INC.: REVENUE, 2013-2015 ($MILLION)
FIGURE 31. BECTON, DICKINSON & CO.: REVENUE, 2013-2015 ($MILLION)
FIGURE 32. CSL BEHRING: REVENUE, 2013-2015 ($MILLION)
FIGURE 33. IMMUCOR: REVENUE, 2013-2015 ($MILLION)
FIGURE 34. NOVARTIS: REVENUE, 2013-2015 ($MILLION)
FIGURE 35. NOVO NORDISK: REVENUE, 2013-2015 ($MILLION)
FIGURE 36. ORTHO CLINICAL DIAGNOSTICS: REVENUE, 2013-2015 ($MILLION)
FIGURE 37. ROCHE DIAGNOSTICS: REVENUE, 2013-2015 ($MILLION)
FIGURE 38. GRIFOLS INTERNATIONAL SA: REVENUE, 2013-2015 ($MILLION)
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
